Literature DB >> 14573653

PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response.

Rakesh Kumar Choudhary1, Sangita Mukhopadhyay, Prachee Chakhaiyar, Naresh Sharma, K J R Murthy, V M Katoch, Seyed E Hasnain.   

Abstract

The variation in sequence and length in the C-terminal region among members of the unique PE (Pro-Glu) and PPE (Pro-Pro-Glu) protein families of Mycobacterium tuberculosis is a likely source of antigenic variation, giving rise to the speculation that these protein families could be immunologically important. Based on in silico analysis, we selected a hypothetical open reading frame (ORF) encoding a protein belonging to the PPE family and having epitopes with predictably higher antigenic indexes. Reverse transcriptase PCR using total RNA extracted from in vitro-cultured M. tuberculosis H37Rv generated an mRNA product corresponding to this gene, indicating the expression of this ORF (Rv2430c) at the mRNA level. Recombinant protein expressed in Escherichia coli was used to screen the sera of M. tuberculosis-infected patients, as well as those of clinically healthy controls (n = 10), by enzyme-linked immunosorbent assay. The panel of patient sera comprised sera from fresh infection cases (category 1; n = 32), patients with relapsed tuberculosis (category 2; n = 30), and extrapulmonary cases (category 3; n = 30). Category 2 and 3 sera had strong antibody responses to the PPE antigen, equal to or higher than those to other well-known antigens, such as Hsp10 or purified protein derivative (PPD). However, a higher percentage of patients belonging to category 1, as opposed to clinically healthy controls, showed stronger antibody response against the PPE protein when probed with anti-immunoglobulin M (IgM) (71 versus 37.5%) or anti-IgG (62.5 versus 28.12%). Our results reveal that this PPE ORF induces a strong B-cell response compared to that generated by M. tuberculosis Hsp10 or PPD, pointing to the immunodominant nature of the protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573653      PMCID: PMC219563          DOI: 10.1128/IAI.71.11.6338-6343.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis.

Authors:  L Ljungqvist; A B Andersen; P Andersen; K Hasløv; A Worsaae; J Bennedsen; I Heron
Journal:  Trop Med Parasitol       Date:  1990-09

2.  Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family.

Authors:  L Ramakrishnan; N A Federspiel; S Falkow
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

3.  The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins?

Authors:  C Espitia; J P Laclette; M Mondragón-Palomino; A Amador; J Campuzano; A Martens; M Singh; R Cicero; Y Zhang; C Moreno
Journal:  Microbiology       Date:  1999-12       Impact factor: 2.777

4.  IgG antibody to purified protein derivative by enzyme-linked immunosorbent assay in the diagnosis of pulmonary tuberculosis.

Authors:  C R Zeiss; S B Kalish; K S Erlich; D Levitz; E Metzger; R Radin; J P Phair
Journal:  Am Rev Respir Dis       Date:  1984-11

5.  Cloning and expression of immunoreactive antigens from Mycobacterium tuberculosis.

Authors:  R L Lim; L K Tan; W F Lau; M C Ming; R Dunn; H P Too; L Chan
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

6.  Heat shock proteins and antigens of Mycobacterium tuberculosis.

Authors:  D B Young; T R Garbe
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens.

Authors:  S Laal; K M Samanich; M G Sonnenberg; S Zolla-Pazner; J M Phadtare; J T Belisle
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

8.  Characterization of novel immunodominant antigens of Mycobacterium tuberculosis.

Authors:  R R Amara; S Shanti; V Satchidanandam
Journal:  Microbiology       Date:  1998-05       Impact factor: 2.777

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins.

Authors:  C Abou-Zeid; T Garbe; R Lathigra; H G Wiker; M Harboe; G A Rook; D B Young
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more
  61 in total

1.  Expression cloning of gamma interferon-inducing antigens of Mycobacterium avium subsp. paratuberculosis.

Authors:  Reiko Nagata; Yoshihiro Muneta; Kazuhiro Yoshihara; Yuichi Yokomizo; Yasuyuki Mori
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis.

Authors:  Michael Strong; Michael R Sawaya; Shuishu Wang; Martin Phillips; Duilio Cascio; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-11       Impact factor: 11.205

3.  Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY.

Authors:  Kanhu C Mishra; Chantal de Chastellier; Yeddula Narayana; Pablo Bifani; Alistair K Brown; Gurdyal S Besra; Vishwa M Katoch; Beenu Joshi; Kithiganahalli N Balaji; Laurent Kremer
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

4.  Association of strong immune responses to PPE protein Rv1168c with active tuberculosis.

Authors:  Nooruddin Khan; Kaiser Alam; Shiny Nair; Vijaya Lakshmi Valluri; Kolluri J R Murthy; Sangita Mukhopadhyay
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

Review 5.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

6.  Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice.

Authors:  Jiu ling Wang; Ya qing Qie; Bing dong Zhu; Hong mei Zhang; Ying Xu; Qing zhong Wang; Jia zhen Chen; Wei Liu; Hong hai Wang
Journal:  Med Microbiol Immunol       Date:  2008-05-20       Impact factor: 3.402

Review 7.  Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum.

Authors:  Marco Ventura; Carlos Canchaya; Andreas Tauch; Govind Chandra; Gerald F Fitzgerald; Keith F Chater; Douwe van Sinderen
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

8.  Lsr2 is a nucleoid-associated protein that targets AT-rich sequences and virulence genes in Mycobacterium tuberculosis.

Authors:  Blair R G Gordon; Yifei Li; Linru Wang; Anna Sintsova; Harm van Bakel; Songhai Tian; William Wiley Navarre; Bin Xia; Jun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-20       Impact factor: 11.205

9.  Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice.

Authors:  Jiuling Wang; Yaqing Qie; Wei Liu; Honghai Wang
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

10.  Genomic comparison of PE and PPE genes in the Mycobacterium avium complex.

Authors:  Nick Mackenzie; David C Alexander; Christine Y Turenne; Marcel A Behr; Jeroen M De Buck
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.